NCT07229417
- Conditions
- Metastatic Endocrine Refractory, Triple Negative Invasive Lobular Carcinoma
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Metastatic Endocrine Refractory
Explore clinical trials studying Metastatic Endocrine Refractory. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study